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Light to moderate intake of alcohol, drinking patterns, and risk  
of cancer: results from two prospective US cohort studies
Yin Cao,1 Walter C Willett,1,2,3 Eric B Rimm,1,2,3 Meir J Stampfer,1,2,3 Edward L Giovannucci1,2,3 
ABSTRACT
ObjeCtives
To quantify risk of overall cancer across all levels of 
alcohol consumption among women and men 
separately, with a focus on light to moderate drinking 
and never smokers; and assess the influence of 
drinking patterns on overall cancer risk.
Design
Two prospective cohort studies.
setting
Health professionals in the United States.
PartiCiPants
88 084 women and 47 881 men participating in the 
Nurses’ Health Study (from 1980) and Health 
Professionals Follow-up Study (from 1986), followed 
until 2010.
Main OutCOMes anD Measures
 Relative risks of cancer.
results
19 269 and 7571 (excluding non-advanced prostate 
cancers) incident cancers were documented among 
women and men, respectively, over 3 144 853 person 
years. Compared with non-drinkers, light to moderate 
drinkers had relative risks of total cancer of 1.02 (95% 
confidence interval 0.98 to 1.06) and 1.04 (1.00 to 1.09; 
Ptrend=0.12) for alcohol intake of 0.1-4.9 and 5-14.9 g/day 
among women, respectively. Corresponding values for 
men were 1.03 (0.96 to 1.11), 1.05 (0.97 to 1.12), and 
1.06 (0.98 to 1.15; Ptrend=0.31) for alcohol intake of 
0.1-4.9, 5-14.9, and 15-29.9 g/day, respectively. 
Associations for light to moderate drinking and total 
cancer were similar among ever or never smokers, 
although alcohol consumption above moderate levels 
(in particular ≥30 g/day) was more strongly associated 
with risk of total cancer among ever smokers than never 
smokers. For a priori defined alcohol related cancers in 
men, risk was not appreciably increased for light and 
moderate drinkers who never smoked (Ptrend=0.18). 
However, for women, even an alcohol consumption of 
5-14.9 g/day was associated with increased risk of 
alcohol related cancer (relative risk 1.13 (95% 
confidence interval 1.06 to 1.20)), driven by breast 
cancer. More frequent and heavy episodic drinking was 
not further associated with risk of total cancer after 
adjusting for total alcohol intake.
COnClusiOn
Light to moderate drinking is associated with 
minimally increased risk of overall cancer. For men who 
have never smoked, risk of alcohol related cancers is 
not appreciably increased for light and moderate 
drinking (up to two drinks per day). However, for 
women who have never smoked, risk of alcohol related 
cancers (mainly breast cancer) increases even within 
the range of up to one alcoholic drink a day. 
Introduction
Heavy alcohol consumption has been linked to 
increased risk of several cancers, including cancer of 
the colorectum, female breast, oral cavity, pharynx, 
 larynx, liver, and esophagus,1  and possibly to a higher 
risk of cancer of the stomach,2 3  pancreas,3 4  lung,3 5  and 
gallbladder.3  However, the association of these cancers 
with light to moderate drinking (up to one alcoholic 
drink per day for women and up to two alcoholic drinks 
per day for men according to the Dietary Guidelines for 
Americans, 20106 ) is less clear.7-9
Extensive literature has documented the J shaped 
associations between alcohol intake and a variety of dis-
eases, including multiple cardiovascular outcomes10 
(such as congestive heart failure,11 12  and stroke13) as well 
as diabetes14  and all cause mortality,15  and possibly cor-
onary heart disease.16  Light to moderate drinkers have a 
lower risk of these disorders than abstainers, and heavy 
drinkers are at the highest risk. However, the potential 
benefits of alcohol consumption have to be weighed 
against the other possible health risks, and cancer is a 
major concern.17  A recent analysis from the United King-
dom’s Million Women Study found that during seven 
years of follow-up, women who drank seven to 14 drinks 
per week had a small increase in risk of all cancers 
 (relative risk 1.05, 95% confidence interval 1.03 to 1.07) 
compared with drinkers who drank fewer than two 
drinks per week.7  The association between light to mod-
erate drinking and overall cancer risk is less clear in the 
United States, where light to moderate drinking is more 
prevalent than in the UK.18 The  influence of drinking 
patterns on overall cancer risk is unclear.
WhAT IS AlReAdy knoWn on ThIS TopIC
Heavy alcohol consumption has been linked to an increased risk of several cancers
However, the association between light to moderate drinking and overall cancer 
risk is less clear in US women and men, among whom light to moderate drinking is 
prevalent 
Furthermore, the role of alcohol independent of smoking is unclear. In studies that 
include smokers, the apparent influence of alcohol on cancer could be partly driven 
by its effect among smokers; thus, findings might not be generalizable to non-
smokers, who now comprise the majority of the US population
WhAT ThIS STudy AddS
Light to moderate drinking (<15 and <30 g of alcohol per day for women and men, 
respectively) was associated with minimally increased risk of overall cancer in both 
women and men
Risk of alcohol related cancer is not appreciably increased for light to moderate 
drinking men (up to two drinks per day) who have never smoked
But in women who have never smoked, the risk of alcohol related cancer (mainly 
breast cancer) increases even within the range up to one alcoholic drink a day
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Although the relation between alcohol and cancer 
has been extensively studied, the role of alcohol inde-
pendent of smoking has not been settled. Two aspects 
are particularly important to consider. Firstly, high 
alcohol drinkers are more likely to smoke—a very strong 
risk factor for cancer—and although smoking has been 
adjusted for in analyses, residual confounding may 
exist.19 20  Secondly, smoking is the major risk factor for 
most alcohol related cancers,21 22  apart from female 
breast cancer. Thus, in studies that include smokers, 
the apparent influence of alcohol on cancer could be 
partly driven by its effect among smokers, and findings 
might not be generalizable to non-smokers, who now 
make up the majority of the population.23
To address these questions, we aimed to evaluate the 
association of alcohol consumption—including quan-
tity (in particular light to moderate intake), frequency, 
and heavy episodic drinking—with risk of cancer in two 
large cohort studies of US women and men. In addition, 
we aimed to determine the dose-response relation of 
alcohol and cancer among never smokers, which would 
be particularly informative for the general public.
Methods
study population
We used two ongoing prospective US cohort studies; the 
Nurses’ Health Study (NHS), including 121 700 female 
nurses aged 30-55 years at enrolment in 1976, and the 
Health Professionals Follow-up Study (HPFS), includ-
ing 51 529 male health professionals aged 40-75 years at 
enrolment in 1986. Participants were mailed question-
naires at enrolment and two years thereafter to collect 
data for demographics, lifestyle factors, medical his-
tory, and disease outcomes, and reported updates in 
dietary intake every four years. The follow-up rates in 
both cohorts were greater than 90%. The study protocol 
was approved by the institutional review boards of the 
Harvard T H Chan School of Public Health and Brigham 
and Women’s Hospital.
assessment of alcohol consumption
Information on alcohol consumption was first collected 
in 1980 in NHS and 1986 in HPFS when participants com-
pleted a semiquantitative food frequency questionnaire 
and reported their average frequency of consumption of 
specific food and beverage items during the previous 12 
months. Alcohol consumption (in grams per day) was 
calculated as the sum of the daily number of drinks mul-
tiplied by the average alcohol content per type of alco-
holic beverage (12.8 g of alcohol per 12 oz serving (355 mL) 
of beer, 11.3 g per 12 oz of light beer, 11.0 g per 4 oz (118 
mL) of wine, and 14.0 g per standard serving (44 mL) of 
liquor). The portion size for red and white wine was 
increased to 5 oz (148 mL) in 2006, and alcohol content 
was adjusted to reflect the changes. Alcohol intake mea-
sured by the food frequency questionnaire was highly 
correlated with intake calculated from detailed food dia-
ries completed by 173 women and 136 men (Spearman 
correlation coefficient =0.90 for women, 0.86 for men), 
and correlated with high density lipoprotein levels.24 
Data for current alcohol consumption were updated in 
1984 and 1986 in NHS, and every four years from 1986 to 
2006 in both cohorts. We calculated the cumulative aver-
age alcohol intake by averaging alcohol consumption 
over time from 1980 for NHS and 1986 for HPFS to the 
current questionnaire cycle and updating data when 
information on alcohol consumption was updated.
Analyses on drinking frequency began with the 1988 
questionnaire in NHS and 1986 questionnaire in HPFS 
when participants were first asked the usual number of 
days when alcohol was consumed in a typical week. Anal-
yses on heavy episodic drinking started from 1988 when 
participants were asked the largest number of alcoholic 
drinks consumed in one day in a typical month (0, 1-2, 3-5, 
6-9, 10-14, or ≥15). The drinking frequency question was 
updated in 1996, 2000, and 2004 in NHS; and updated in 
1988, 1998, and every two years from 2002 in HPFS. The 
assessment of heavy episodic drinking was updated in 
1988, 1996, 2000, and 2004 in NHS; and updated in 1992, 
1996, and every two years from 2004 in HPFS.
ascertainment of cancer
In each cohort, participants reported cancer and other 
disease endpoints in biennial questionnaires. Research-
ers obtained permission from the study participants to 
obtain their medical records and pathological reports 
and abstracted the information on anatomical location, 
stage, and histological type of the cancer. Confirmed 
cancers were defined according to ICD-9 (international 
classification of diseases, 9th revision).
statistical analysis
We excluded participants with cancer, implausible 
energy intakes (reported as <600 or >3600 kcal/day 
for  women, and <800 or >4200 kcal/day for men; 
1 kcal=4.18 kJ), or missing alcohol intake at baseline. As 
the main analysis, we examined cumulative average 
consumption of alcohol (0, 0.1-4.9, 5-14.9, 15-29.9, 30-44.9, 
≥45 g/day) in relation to risk of any type of cancer. Most 
prostate cancer detected through prostate specific anti-
gen screening is indolent; therefore, we only included 
participants with advanced or lethal prostate cancer. 
This group was defined as participants with regionally 
invasive or metastatic prostate cancer at diagnosis 
(stages ≥T3b, N1, or M1), or who developed metastases 
or died from prostate cancer during follow-up.
Person years of follow-up accrued from the date of 
return of the 1980 questionnaire in NHS and 1986 ques-
tionnaire in HPFS until either the date of diagnosis of any 
type of cancer, death, or the end of follow-up (June 2010 
for NHS and January 2010 for HPFS), whichever came 
first. We used Cox proportional hazards models with time 
varying alcohol consumption and covariates to compute 
hazard ratios as estimates for age adjusted and multivari-
able adjusted relative risks and 95% confidence intervals. 
To control as finely as possible for confounding by age, 
calendar time, and any possible two way interactions 
between these two time scales, we stratified the analysis 
jointly by age in months at start of follow-up and calen-
dar year of the current questionnaire cycle. The time 
scale for the analysis was months since the start of the 
current questionnaire cycle, which is equivalent to age in 
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months because of the way we structured the data and 
formulate the model for analysis. 
Departures from the proportional hazards assump-
tion was tested by likelihood ratio tests comparing 
models with and without the interaction terms of age or 
calendar time by categories of alcohol consumption. We 
found no significant violation of the proportionality 
assumption (P>0.05 for all tests). In addition to risk of 
total cancer, we also investigated the association with 
alcohol related cancers (cancer of the colorectum, 
female breast, oral cavity, pharynx, larynx, liver, and 
esophagus), as defined by the International Agency for 
Cancer Research,1 and other cancer sites.
We adjusted for the following characteristics:
•	 Race (white v non-white)
•	 Height (continuous)
•	 Body mass index (by quintiles)
•	 Family history of cancer (yes v no)
•	 Physical exam (yes v no)
•	 History of colonoscopy or sigmoidoscopy (yes v no)
•	 Smoking (pack years in the following categories: 
never smoker, 1-4.9, 5-19.9, 20-39.9, ≥40)
•	 Leisure time physical activity (metabolic equivalent 
of task hours per week; by quintiles)
•	 Regular use of aspirin (yes v no)
•	 Current use of multivitamin (yes v no)
•	 Total energy intake (by quintiles)
•	 Red and processed meat intake (by quintiles). 
We also adjusted for the prostate specific antigen test 
(yes v no) among men, and menopause status (pre-
menopause or postmenopause), postmenopausal hor-
mone use (never, past, or current), and use of 
mammograms (yes v no) among women.
To capture potential confounding by diet, we 
adjusted for the alternate health eating index (AHEI) 
2010.25  The index features higher consumption of vege-
tables (excluding potatoes), whole fruit, whole grains, 
nuts and legumes, long chain omega 3 fatty acids, and 
polyunsaturated fat; lower consumption of sugar 
sweetened beverages, red or processed meat, sodium, 
and trans fats; and moderate alcohol consumption. 
Dietary adherence to the AHEI 2010 has been associ-
ated with a reduced risk of cardiovascular disease, dia-
betes, and cancer.26 In the present analysis, a modified 
AHEI 2010 without alcohol consumption was used. All 
variables including alcohol consumption variables 
(apart from race and height) were updated from fol-
low-up questionnaires and considered as time varying 
covariates in the Cox models.
We performed tests for linear trends using alcohol 
consumption as a continuous variable. In addition to 
evaluating the trend across all levels of alcohol intake, 
we also restricted intake to less than 15 g/day for women 
and less than 30 g/day for men, to evaluate the trend 
within light to moderate alcohol consumption. We used 
restricted cubic splines to non-parametrically examine 
the possible non-linear relation between alcohol con-
sumption and risk of cancer or alcohol related cancer. 
To test for non-linearity, we used the likelihood ratio 
test, which compared the model with only the linear 
term to the model with the linear and cubic spline 
terms. We also examined whether the associations 
between alcohol and cancer differed by age (<65 years v 
≥65 years), body mass index (<25 v ≥25), family history 
of colorectal cancer or female breast cancer (yes v no), 
current use of multivitamin (yes v no), regular use of 
aspirin (yes v no), dietary adherence to AHEI 2010 
(median value or over v less than median value), and 
smoking history (never v ever). Tests for interaction 
were performed using likelihood ratio tests.
For drinking patterns, we evaluated the association 
between frequency of drinking, as indicated by how many 
days alcohol was consumed in a typical week (0, 1-2, 3-4, 
5-6, 7); heavy episodic drinking, as assessed by the largest 
number of alcoholic drinks consumed in one day in a 
 typical month (0, 1-2, 3-5, ≥6); and risk of cancer. Tests for 
linear trends were performed using frequency of drinking 
as a continuous variable, and the median of each category 
of heavy episodic drinking as a continuous variable.
There were concerns that former heavy drinkers 
before the initiation of the cohorts may be included in 
the reference group. Therefore, we conducted sensitiv-
ity analyses excluding participants who reported no 
alcohol intake at baseline but greatly decreased their 
alcohol intake in the previous 10 years (2922 women, 
6406 men). We also conducted analyses including all 
the non-advanced prostate cancers to the total of all 
cancers. We evaluated the association between baseline 
alcohol consumption (1980 in NHS and 1986 in HPFS) 
and risk of cancer. All analyses were performed using 
SAS version 9.3, with a two sided significance of P<0.05.
Patient involvement
No patients were involved in setting the research ques-
tion or the outcome measures, nor were they involved in 
the design and implementation of the study. There are 
no plans to involve patients in dissemination.
Results
During up to 30 years of follow-up of 88 084 women and 
47 881 men, 19 269 and 7571 incident cancers were diag-
nosed, respectively. Median consumption of alcohol was 
1.8 g/day in women and 5.6 g/day in men at baseline (1980 
in NHS and 1986 in HPFS). Abstainers or heavy drinkers 
were less likely than light and moderate drinkers to have 
had a regular physical exam and be screened for colorec-
tal, prostate, or breast cancer (table 1). They also engaged 
in fewer physical activities and had lower AHEI 2010 
dietary scores. Heavy drinkers were more likely to be ever 
smokers, and had higher pack years of smoking.
Overall, alcohol consumption was significantly 
associated with increased risk of cancer, for both 
women (Ptrend<0.001) and men (Ptrend=0.006; table 2 ). 
Non- parametric regression curves suggested that the 
 dose-response relation were linear (P for curvature=0.79 
for women and 0.75 for men), and that the increased 
risk of cancer appear to be significant at lower levels of 
alcohol consumption in women than in men (fig 1).
Compared with non-drinkers, relative risks of total 
cancer for light to moderate drinkers were 1.02 (95% 
confidence interval 0.98 to 1.06) and 1.04 (1.00 to 1.09) 
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for alcohol intake of 0.1-4.9 and 5-14.9 g/day among 
women, respectively (Ptrend=0.12). Corresponding values 
for men were 1.03 (0.96 to 1.11), 1.05 (0.97 to 1.12), and 
1.06 (0.98 to 1.15) for alcohol intake of 0.1-4.9, 5-14.9, and 
15-29.9 g/day (Ptrend=0.31), respectively. Results were 
similar if we excluded non-drinkers at baseline (in 1980 
for women and 1986 for men) who had greatly decreased 
their alcohol intake in the previous 10 years (web table S1), 
or non-advanced prostate cancers were included (web 
table S2), or baseline alcohol intake (in 1980 for women 
and 1986 for men) was evaluated instead of the cumula-
tive average (web table S3). All alcohol beverage types 
showed an association suggesting that the ethanol but 
not other components of the beverages was the primary 
factor (web table S4).
The associations between light to moderate drinking 
and risk of total cancer were similar regardless of smok-
ing history (never or ever smokers). However, alcohol 
consumption above moderate levels, in particular at 
least 30 g/day (Pinteraction=0.06 for women and 0.11 for 
men), was more strongly associated with risk of cancer 
among ever than among never smokers (web table S5, 
web figs S1 and S2). Joint analysis of alcohol intake and 
smoking suggested that, compared with alcohol, smok-
ing was a much stronger risk factor for cancer, and inde-
pendent influence of alcohol, especially in the range of 
light to moderate drinking, could be minimal (fig 2, web 
table S6). The association between alcohol and total 
cancer was not appreciably different by age, multivita-
min or aspirin use, AHEI 2010, or family history of breast 
cancer among women, but was stronger among people 
with a family history of colorectal cancer (although 
interactions were not significant; web table S5).
For a priori defined alcohol related cancers (affecting 
the colorectum, female breast, oral cavity, pharynx, 
 larynx, liver, and esophagus), 9016 and 1611 cases were 
documented during follow-up among women and men, 
respectively (web table S7). Breast cancer was the 
table 1  | age standardized characteristics of person years according to alcohol consumption (nurses’ Health study 1980-2010, Health Professionals 
Follow-up study 1986-2010)
Characteristic
Cumulative average consumption of alcohol (g/day)
0 0.1-4.9 5-14.9 15-29.9 30-44.9 ≥45
Women
Age (years)* 58.3 (11.1) 59.7 (10.8) 59.2 (10.7) 60.1 (10.5) 58.8 (10.3) 58.0 (9.9)
White (%) 96 98 98 99 99 99
Family history of cancer (%) 34 38 38 37 34 33
Height (cm) 163 (6) 164 (6) 164 (6) 164 (6) 164 (6) 164 (6)
Body mass index 26.2 (5.2) 25.6 (4.7) 24.3 (3.8) 23.9 (3.6) 24.0 (3.8) 24.0 (3.9)
Postmenopause (%) 74 75 75 76 77 77
Current hormone therapy use (%) 25 30 32 33 27 24
Physical examination in past 2 years (%) 68 74 73 74 68 65
History of colonoscopy or sigmoidoscopy (%) 31 37 36 36 32 30
Mammogram in past 2 years (%) 66 74 75 76 68 64
Regular aspirin use (%) 39 41 43 45 46 44
Current use of multivitamin (%) 46 51 52 50 48 48
Physical activity (MET h/week) 13.5 (16.5) 15.8 (17.7) 18.0 (19.6) 18.1 (19.3) 15.7 (18.3) 13.7 (16.5)
Never smoker (%) 63 47 34 25 19 18
No of pack years among ever smokers 25.0 (20.7) 21.9 (19.0) 22.2 (19.1) 26.1 (20.8) 33.4 (23.5) 38.3 (25.6)
Calorie intake from sources other than alcohol (kcal/day)† 1648 (463) 1653 (437) 1611 (437) 1586 (427) 1524 (430) 1555 (446)
Red and processed meat in diet (no of servings/week) 7.0 (4.1) 6.6 (3.5) 6.6 (3.5) 6.7 (3.5) 7.2 (3.8) 7.7 (4.4)
Alternate healthy eating index  2010‡ 44.7 (10.0) 45.7 (9.5) 46.3 (9.2) 45.8 (9.1) 43.5 (9.1) 41.9 (9.3)
Men
Age (years)* 62.2 (11.0) 62.6 (11.0) 62.7 (10.7) 63.3 (10.6) 63.5 (10.5) 63.0 (10.2)
White (%) 87 89 91 92 93 93
Family history of cancer (%) 23 27 27 28 25 26
Height (cm) 178 (7) 178 (7) 178 (7) 179 (7) 179 (7) 179 (7)
Body mass index 25.9 (3.8) 25.9 (3.5) 25.7 (3.3) 25.7 (3.2) 25.7 (3.2) 26.0 (3.3)
Physical examination in past 2 years (%) 71 76 77 77 75 72
History of colonoscopy or sigmoidoscopy (%) 42 52 52 53 48 44
Prostate specific antigen test in past 2 years (%) 24 34 35 36 30 26
Regular aspirin use (%) 35 39 42 46 46 44
Current use of multivitamin (%) 41 46 47 48 45 46
Physical activity (MET h/week) 26.7 (29.2) 28.6 (27.7) 31.9 (28.9) 33.2 (30.6) 30.1 (29.1) 27.9 (27.7)
Never smoker (%) 64 54 45 35 27 23
No of pack years among ever smokers 26.6 (20.7) 23.3 (18.5) 22.4 (17.6) 24.0 (18.0) 29.1 (20.3) 31.7 (22.1)
Calorie intake from sources other than alcohol (kcal/day)† 1912 (579) 1891 (549) 1895 (545) 1915 (540) 1887 (547) 1910 (543)
Red and processed meat in diet (no of servings/week) 6.2 (4.8) 6.0 (4.4) 6.3 (4.3) 6.8 (4.3) 7.5 (4.7) 8.1 (4.9)
Alternate healthy eating index  2010‡ 47.5 (10.8) 48.4 (10.2) 48.6 (9.9) 47.9 (9.5) 45.9 (9.5) 44.2 (9.4)
MET h/week=metabolic equivalent of task hours per week.
*All values other than age have been directly standardized to age distribution (in 5-year age group) of all the participants. Mean (SD) was presented for continuous variables.
†1 kcal=4.18 kJ.
‡Without alcohol intake.
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 leading alcohol related cancer in women, whereas col-
orectal cancer was the major alcohol associated cancer 
in men. Among women, even an alcohol consumption of 
5-14.9 g/day was associated with an increased risk of 
these cancers (relative risk 1.13 (95% confidence interval 
1.06 to 1.20), primarily driven by breast cancer (table 2), 
and similar for never and ever smokers (fig 2, web table 
S8) after controlling for obesity and other covariates. 
By contrast, risk of alcohol related cancers increased 
among light and moderate male drinkers who ever 
smoked (Ptrend=0.006) but not among those who never 
smoked (Ptrend=0.18). Consumption of at least 30 g/day 
of alcohol was more strongly associated with risk of 
cancer among ever than never smokers (Pinteraction=0.06 
for women and 0.03 for men). The association between 
alcohol and alcohol related cancers was also stronger 
for ages 65 and above and for those with a family history 
of colorectal cancer, although interactions were not sig-
nificant. No association between alcohol consumption 
and risk of other cancers was detected (table 2).
Regularity of drinking and heavy episodic drinking 
were weakly associated with increased risk of total 
cancer, although the associations were not signifi-
cant after adjusting for cumulative alcohol consump-
tion (table 3). Joint analyses of total alcohol 
consumption and drinking patterns suggested that 
total alcohol consumption drives the association 
with risk of cancer (web tables S9 and S10). For alco-
hol related cancers, increased frequency of drinking 
was associated with increased risk in men but not in 
women (web table S11), whereas heavy episodic 
drinking was associated with increased risk of 
 alcohol related cancer in women but not in men after 
adjusting for total alcohol (web table S12).
discussion
Principal findings
In two large prospective cohort studies in the USA, the 
Nurses’ Health Study (NHS) and Health Professionals 
Follow-up Study (HPFS), we quantified risk of cancer 
table 2  | alcohol consumption and risk of total cancer, alcohol related cancer, and other cancer
 
Cumulative average consumption of alcohol (g/day) Ptrend 
(all)§
Ptrend 
(moderate)¶0 0.1-4.9 5-14.9 15-29.9 30-44.9 ≥45
Women
Total cancer (n=19 269)
 Cases (no) 3981 8176 4284 1932 687 209 — —
 Person years (no) 515 558 953 459 495 987 188 987 62 318 17 913 — —
 Age adjusted RR (95% CI) 1 (ref) 1.05 (1.01 to 1.09) 1.08 (1.03 to 1.12) 1.23 (1.16 to 1.29) 1.40 (1.30 to 1.52) 1.56 (1.36 to 1.79) <0.001 0.004
 Multivariable RR (95% CI)* 1 (ref) 1.02 (0.98 to 1.06) 1.04 (1.00 to 1.09) 1.13 (1.07 to 1.19) 1.21 (1.12 to 1.32) 1.30 (1.13 to 1.50) <0.001 0.12
Alcohol related cancer (n=9016)†
 Cases (no) 1839 3762 2064 914 329 108
 Age adjusted RR (95% CI) 1 (ref) 1.06 (1.00 to 1.12) 1.14 (1.07 to 1.21) 1.27 (1.17 to 1.38) 1.45 (1.29 to 1.64) 1.71 (1.41 to 2.08) <0.001 <0.001
 Multivariable RR (95% CI)* 1 (ref) 1.04 (0.99 to 1.11) 1.13 (1.06 to 1.20) 1.24 (1.14 to 1.35) 1.42 (1.25 to 1.60) 1.66 (1.36 to 2.02) <0.001 <0.001
Alcohol related cancer without  
breast cancer (n=1972)
 Cases (no) 429 822 414 190 83 34
 Age adjusted RR (95% CI) 1 (ref) 1.01 (0.89 to 1.13) 0.99 (0.86 to 1.13) 1.11 (0.94 to 1.32) 1.56 (1.23 to 1.97) 2.29 (1.61 to 3.25) <0.001 0.63
 Multivariable RR (95% CI)* 1 (ref) 1.01 (0.90 to 1.14) 1.00 (0.87 to 1.15) 1.08 (0.90 to 1.29) 1.40 (1.10 to 1.78) 1.99 (1.39 to 2.84) <0.001 0.44
Other cancer (n=10 253)
 Cases (no) 2142 4414 2220 1018 358 101
 Age adjusted RR (95% CI) 1 (ref) 1.03 (0.98 to 1.09) 1.02 (0.96 to 1.09) 1.18 (1.10 to 1.28) 1.36 (1.22 to 1.52) 1.43 (1.17 to 1.74) <0.001 0.91
 Multivariable RR (95% CI)* 1 (ref) 1.00 (0.95 to 1.06) 0.97 (0.91 to 1.03) 1.03 (0.96 to 1.12) 1.06 (0.95 to 1.19) 1.06 (0.87 to 1.30) 0.29 0.07
Men
Total cancer (n=7571)‡
 Cases (no) 1271 1998 2127 1221 640 314
 Person years (no) 166 243 253 036 261 613 138 955 60 721 30 063
 Age adjusted RR (95% CI) 1 (ref) 1.04 (0.97 to 1.12) 1.08 (1.01 to 1.16) 1.14 (1.05 to 1.23) 1.32 (1.20 to 1.46) 1.34 (1.18 to 1.52) <0.001 0.002
 Multivariable RR (95% CI)* 1 (ref) 1.03 (0.96 to 1.11) 1.05 (0.97 to 1.12) 1.06 (0.98 to 1.15) 1.15 (1.04 to 1.27) 1.13 (0.99 to 1.28) 0.006 0.31
Alcohol related cancer (n=1611)†
 Cases (no) 269 381 426 282 161 92
 Age adjusted RR (95% CI) 1 (ref) 0.96 (0.82 to 1.12) 1.04 (0.89 to 1.21) 1.28 (1.08 to 1.52) 1.60 (1.31 to 1.95) 1.89 (1.49 to 2.41) <0.001 0.001
 Multivariable RR (95% CI)* 1 (ref) 0.98 (0.83 to 1.15) 1.06 (0.90 to 1.24) 1.26 (1.06 to 1.50) 1.48 (1.21 to 1.81) 1.62 (1.27 to 2.08) <0.001 0.004
Other cancer (n=5960)
 Cases (no) 1002 1617 1701 939 479 222
 Age adjusted RR (95% CI) 1 (ref) 1.07 (0.99 to 1.16) 1.09 (1.01 to 1.18) 1.10 (1.00 to 1.20) 1.25 (1.12 to 1.39) 1.19 (1.03 to 1.38) <0.001 0.07
 Multivariable RR (95% CI)* 1 (ref) 1.05 (0.97 to 1.13) 1.04 (0.96 to 1.13) 1.01 (0.92 to 1.11) 1.07 (0.96 to 1.20) 1.00 (0.86 to 1.16) 0.95 0.69
RR=relative risk; ref=reference.
*Adjusted for age, race, height, body mass index, family history of cancer, physical exam in past two years, history of colonoscopy or sigmoidoscopy, smoking in pack years, physical activity, 
regular aspirin use, multivitamin use, total energy intake (without alcohol), red and processed meat intake, alternate healthy eating index 2010 (without alcohol); prostate specific antigen test 
in past two years (men only); and menopause status, postmenopausal hormone use, and mammogram in past two years (women only).
†Included cancers of the colorectum, breast (for women), oral cavity, pharynx, larynx, liver, and esophagus.
‡For prostate cancer, only advanced cases were included.
§Calculated using continuous alcohol consumption.
¶Calculated using continuous alcohol consumption and restricted to women with alcohol consumption lower than 15 g/day or men with alcohol consumption lower than 30 g/day, respectively.
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across all levels of alcohol consumption among women 
and men separately, with a focus on light to moderate 
drinking and never smokers. Overall, light to moderate 
drinking (alcohol intake of <15 g/day for women and 
<30 g/day for men) was associated with a small but 
non-significant increase in cancer risk in both women 
and men. For men, the association with alcohol related 
cancers was driven largely by smoking, and light to 
moderate drinking did not appreciably increase risk in 
never smokers. Among women, even consumption of 
5-14.9 g of alcohol per day was associated with increased 
risk of alcohol related cancers, mainly breast cancer. 
Regularity of drinking and heavy episodic drinking was 
not significantly associated with increased risk of can-
cer, after adjustment for total alcohol consumption.
Comparison with other studies
It is estimated that alcohol consumption has caused 
3.6% of all cancers worldwide (1.7% in women and 
5.2% in men),27  and 3.2% to 3.7% of cancer deaths in 
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Fig 2 | risk of total and alcohol related cancer jointly by alcohol consumption and smoking history
Women (total cancer)
Alcohol consumption (g/day)
R
el
at
iv
e 
ri
sk
0
1.0
1.5
2.0
2.5
3.0
0.5
0 10 20 30 40
P for curvature: 0.79
50 60
Men (total cancer)
Alcohol consumption (g/day)
0 10 20 30 40
P for curvature: 0.75
50
Women (alcohol related cancer)
R
el
at
iv
e 
ri
sk
0
1.0
1.5
2.0
2.5
3.0
0.5
P for curvature: 0.69
Men (alcohol related cancer)
P for curvature: 0.98
60
Fig 1  | non-parametric regression curves showing the association between alcohol consumption and risk of cancer (total 
and alcohol related). blue lines=relative risk; dotted lines=95% confidence intervals
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the USA.28  These estimates were primarily based on 
relative risks from studies focused on high intake of 
alcohol. Indeed, few prospective studies have exam-
ined the association of light to moderate alcohol con-
sumption, the most prevalent levels of alcohol intake, 
with risk of total cancer. Our findings that light to mod-
erate alcohol drinking was not appreciably associated 
with risk of total cancer in women and men was consis-
tent with findings from women in the British Million 
Women study.7
We also found that alcohol consumption above moder-
ate levels was more strongly associated with risk of cancer 
among ever smokers than among never smokers. This 
suggests that the independent influence of alcohol on 
cancer risk could be limited to populations such as the 
USA, where the prevalence of smoking is steadily decreas-
ing and light and moderate drinking is prevalent. Indeed, 
a large consortium analysis has suggested that among 
never smokers, the association between alcohol con-
sumption and the risk of head and neck cancer is appar-
ent only at high doses (at least three drinks per day), and 
confined to pharyngeal and laryngeal cancers.29
The Million Women Study researchers also found 
that increasing alcohol intake was associated with an 
increased risk of cancers of the upper aerodigestive 
tract among current smokers but not among never 
smokers.7  However, among both never and ever smok-
ing women, an increase in risk of alcohol related can-
cers, mainly breast cancers, was observed for up to one 
drink of alcohol per day, which was consistent with 
findings from our previous analysis on breast cancer as 
well as the British Million Women study that moderate 
alcohol intake was associated with a modest increased 
risk of breast cancer.7  30
Genetic predisposition should also be taken into 
account when discussed individually on the most appro-
priate levels of drinking. Although we have limited infor-
mation on family history of these cancers, we observed 
stronger association of alcohol intake and overall cancer 
among people who had a family history of colorectal 
cancer31 but minimal differences among people with ver-
sus without family history of breast cancer.
Potential mechanisms
Acetaldehyde, the first and most toxic ethanol metabo-
lite, is considered a cancer causing agent.32  Ethanol 
could also stimulate carcinogenesis by inhibiting DNA 
methylation and interacting with retinoid metabolism. 
Bacterial microbiota contributes to the metabolism of 
alcohol and could mediate many disease promoting and 
genotoxic effects of alcohol,33  in particular for colorectal 
cancer,34  as well as cancers of the oral cavity, where 
saliva acetaldehyde was found to be high for increasing 
ethanol intake and where further metabolism of acetal-
dehyde is limited.35  Breast tissue might be more suscep-
tible to alcohol than other organs. Probable explanations 
involve increased estrogen and androgen levels.30  36
strengths and limitations of the study
Study strengths included detailed prospective and 
updated assessment of alcohol consumption, including 
both quantity and drinking patterns, long term fol-
low-up, and large number of participants to examine 
association by smoking history and other risk profiles, as 
well as parallel assessment in women and men. Limita-
tions included self reported alcohol use, but this has pre-
viously been shown to be highly reproducible within our 
cohorts and strongly correlated with levels of high den-
sity lipoprotein cholesterol.24  Furthermore, measure-
ment error does not substantially affect estimates of the 
alcohol association.37 In addition, since health profes-
sionals are generally health conscious, we had limited 
power to fully evaluate the influence of binge drinking 
and extremely high levels of alcohol consumption on risk 
of cancer, as well as risk among current smokers. Finally, 
residual confounding could not be excluded.
Conclusions
In summary, our study provides a comprehensive 
assessment of the relation between alcohol intake, 
table 3 | Drinking patterns and risk of total cancer
 
Women Men
Cases 
(no)
Person 
years (no)
Multivariable  
rr (95% Ci)*
Multivariable  
rr (95% Ci)†
Cases 
(no)
Person 
years (no)
Multivariable  
rr (95% Ci)*
Multivariable  
rr (95% Ci)†
Frequency of drinking (drinks/week) 
0 5166 512 091 1 (ref) 1 (ref) 1633 187 897 1 (ref) 1 (ref)
1-2 3069 326 224 1.00 (0.96 to 1.05) 0.98 (0.93 to 1.03) 1499 187 663 1.02 (0.95 to 1.10) 0.99 (0.90 to 1.08)
3-4 1236 119 744 1.03 (0.97 to 1.10) 1.00 (0.93 to 1.07) 727 90 762 1.00 (0.92 to 1.10) 0.95 (0.85 to 1.07)
5-6 1385 112 878 1.09 (1.03 to 1.17) 1.02 (0.94 to 1.10) 826 92 965 1.01 (0.93 to 1.11) 0.94 (0.84 to 1.07)
7 986 81 299 1.08 (1.01 to 1.16) 0.97 (0.88 to 1.06) 957 84 137 1.09 (1.00 to 1.19) 0.99 (0.87 to 1.12)
Ptrend‡ — — <0.001 0.98 — — 0.10 0.72
Highest no of drinks consumed in 1 day
0 4881 453 421 1 (ref) 1 (ref) 1403 149 861 1 (ref) 1 (ref)
1-2 5969 570 288 1.04 (1.00 to 1.08) 1.02 (0.97 to 1.07) 2206 231 914 1.02 (0.95 to 1.09) 0.98 (0.90 to 1.07)
3-5 2040 207 471 1.06 (1.00 to 1.12) 0.99 (0.93 to 1.06) 903 103 447 1.05 (0.96 to 1.15) 0.97 (0.87 to 1.09)
≥6 498 44 084 1.13 (1.03 to 1.24) 1.05 (0.95 to 1.17) 224 24 735 1.13 (0.98 to 1.31) 1.03 (0.87 to 1.22)
Ptrend§ — — <0.001 0.18 — — 0.16 0.96
RR=relative risk; ref=reference.
*Adjusted for the same covariates as listed in table 2.
†Adjusted for total alcohol intake.
‡Calculated using continuous days of alcohol consumption.
§Calculated using the median of each category as a continuous variable.
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including quantity and drinking patterns, and risk of 
cancer, with a focus on light to moderate drinking and 
never smokers. Light to moderate drinking is associated 
with small and non-significant increased risk of overall 
cancer. For men, the association with alcohol related 
cancers was primarily observed among smokers, and 
light to moderate drinking did not appreciably increase 
risk in never smokers. Among women, even consump-
tion of up to one drink per day was associated with 
increased risk of alcohol related cancers (mainly breast 
cancer). Decisions on levels of alcohol consumption 
should also incorporate information on smoking history 
and familial predispositions to alcohol related cancers.
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